|
SF3A3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.737400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.813700E-02 |
| Normal-vs-Stage2 |
4.211900E-04 |
| Normal-vs-Stage3 |
1.358410E-04 |
| Normal-vs-Stage4 |
7.235600E-03 |
| Stage1-vs-Stage2 |
2.434300E-02 |
| Stage1-vs-Stage3 |
3.776200E-03 |
| Stage1-vs-Stage4 |
1.536020E-01 |
| Stage2-vs-Stage3 |
9.700600E-01 |
| Stage2-vs-Stage4 |
3.931800E-01 |
| Stage3-vs-Stage4 |
3.386400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.637200E-03 |
| Normal-vs-AfricanAmerican |
1.360730E-04 |
| Normal-vs-Asian |
6.680000E-01 |
| Caucasian-vs-AfricanAmerican |
4.242300E-02 |
| Caucasian-vs-Asian |
1.692800E-01 |
| AfricanAmerican-vs-Asian |
3.998500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.567100E-04 |
| Normal-vs-Female |
1.182210E-02 |
| Male-vs-Female |
2.942400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.757030E-01 |
| Normal-vs-Age(41-60Yrs) |
5.775300E-03 |
| Normal-vs-Age(61-80Yrs) |
2.421700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.480130E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.485600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.659400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.867600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.942600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.176170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.488400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.586600E-01 |
| Normal-vs-Grade 2 |
2.008400E-01 |
| Normal-vs-Grade 3 |
1.87243999999476E-05 |
| Normal-vs-Grade 4 |
2.339700E-03 |
| Grade 1-vs-Grade 2 |
3.652000E-01 |
| Grade 1-vs-Grade 3 |
1.688470E-02 |
| Grade 1-vs-Grade 4 |
6.238300E-02 |
| Grade 2-vs-Grade 3 |
1.96577000000087E-05 |
| Grade 2-vs-Grade 4 |
1.315800E-02 |
| Grade 3-vs-Grade 4 |
5.733800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.994200E-01 |
| Normal-vs-ccB subtype |
1.74168999999003E-05 |
| ccA subtype-vs-ccB subtype |
1.11329999996634E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.064400E-03 |
| Normal-vs-N1 |
1.502200E-01 |
| N0-vs-N1 |
9.810600E-01 |
|
|
